RARaya Almazrouei

Raya Almazrouei

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Raya Almazrouei has a total of 72 co-authors. Here are the top co-authors by number of shared publications:

  • Bachar Afandi

    Endocrine Division, Department of Medicine, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates

    3 shared publications
  • Mohamed Alqedra

    Department of Internal Medicine, Tawam Hospital , Al Ain

    3 shared publications
  • Mouza Alnuaimi

    Department of Endocrinology, Tawam Hospital, Al Ain, United Arab Emirates

    3 shared publications
  • Saif Al-Shamsi

    Department of Internal Medicine, College of Medicine and Health Sciences, United Arab Emirates University

    3 shared publications
  • Adnan Agha

    Department of Internal Medicine, College of Medicine and Health Sciences, United Arab Emirates University, United Arab Emirates

    2 shared publications
  • Aisha AlShamsi

    Division of Genetics and Metabolic, Department of Paediatrics, Tawam Hospital , Al Ain , United Arab Emirates

    2 shared publications

Latest Publications

  • Open Access

    Cannulated Prolactin Testing in Mild Hyperprolactinemia: Clinical Utility, Evidence, and Future Directions

    by Rana Al Juhmani, Aya Altaleb, Mohammed Alshaibani, Sara Saad, Eman Khaled, Raya Almazrouei

    Hyperprolactinemia is a common finding in endocrine practice. An underappreciated cause of mild prolactin elevation is venipuncture-induced stress, which may lead to false-positive diagnoses and unnecessary downstream investigations. Cannulated prolactin testing (CPT) was developed to minimize procedural stress and exploit prolactin's short half-life to unmask true basal secretion. This narrative review examines the physiological rationale, clinical evidence, and practical application of CPT in the evaluation of suspected venipuncture-induced mild hyperprolactinemia. Across predominantly retrospective cohorts, CPT results in prolactin normalization in approximately 25 to 70% of patients with mild hyperprolactinemia, indicating that many mild elevations are transient and nonpathological. Failure to normalize during CPT is consistently associated with a higher prevalence of pituitary abnormalities on magnetic resonance imaging (MRI), supporting its role as a gatekeeper to imaging. Available data suggest that the diagnostic yield of CPT is greatest when referral prolactin concentrations are below approximately two to three times the upper limit of normal, although there is no universally agreed exact threshold. Despite its clinical relevance, CPT remains variably implemented and methodologically heterogeneous across studies. Prospective, standardized studies are needed to define optimal protocols and identify the highest-yield clinical indications.

  • Open Access

    Romosozumab Efficacy in Osteoporosis: Influence of Diabetes and Previous Antiresorptive Therapy: A Single Centre Experience

    by Hind Alshamsi, Duha Alnaqbi, Charu Sharma, Romona D Govender, Raya Almazrouei

    Background: Romosozumab is an anabolic agent approved for the treatment of severe osteoporosis in postmenopausal women and in men at high risk of fracture. However, real-world data on its effectiveness, particularly in patients with diabetes mellitus (DM) or prior exposure to antiresorptive therapy, remain limited. Methods: Adult patients (⩾18 years) who received romosozumab between January 2021 and May 2024 and had both baseline and post-treatment dual-energy X-ray absorptiometry (DEXA) scans were included. Bone mineral density (BMD) at the lumbar spine, total hip and femoral neck was assessed before and after 12 months of therapy. Subgroup analyses were undertaken according to diabetes status and previous antiresorptive therapy exposure. Results: Eighty-seven patients were included (mean age 66.7 ± 13.0 years; 94.3% female). The median percentage increase in lumbar spine BMD was 6.7% (IQR 1.3-12.6), while increases at the total hip and femoral neck were 2.9% (IQR −1.1 to 9.1) and 2.3% (IQR −3.9 to 9.7), respectively. Patients without diabetes demonstrated significantly greater BMD gains than those with diabetes at the lumbar spine (9.9% vs 3.1%; P = .020), total hip (4.1% vs 0.3%; P = .027), and femoral neck (3.9% vs 0.1%; P = .028). Similarly, treatment-naïve patients had greater improvements in total hip BMD compared with those with prior antiresorptive exposure (8.3% vs 2.2%; P = .004). Conclusion: Romosozumab significantly increased BMD at the lumbar spine, total hip and femoral neck after 12 months of treatment. The response was more pronounced in patients without diabetes and those who were treatment-naïve, suggesting that metabolic status and previous antiresorptive therapy may influence treatment effectiveness. Prospective studies are warranted to evaluate long-term fracture outcomes and the durability of these effects.


  • Open Access

    Thyroid and cortisol endocrinopathies and survival in cancer patients treated with immune checkpoint inhibitors in UAE

    by Mohamed Alqedra, Bara Fahmayee, Lina Wahba, Jawaher Ansari, Romona D Govender, Saif Al-Shamsi, Raya Almazrouei

    Background Immune checkpoint inhibitors (ICIs) are associated with immune-related adverse events (irAEs) of which endocrinopathies are among the most frequent. This study aimed to identify thyroid and cortisol-related endocrine-related adverse events (ERAEs) in a cohort of patients treated with ICIs and to examine survival differences between patients who developed endocrinopathies and those who did not. Methods We conducted a retrospective review of electronic medical records of adult patients who received ICIs between 2018 and 2023. Data were collected specifically on thyroid and cortisol-related ERAEs. Results Among 616 patients, 59 (9.6%) developed thyroid or cortisol-related ERAEs. The mean time to onset was 22.7 weeks. All thyroid-related events were post-thyroiditis hypothyroidism (n = 55), while all cortisol-related events were due to adrenocorticotropic hormone (ACTH) deficiency (n = 11). The majority of these events occurred in patients treated with anti–PD-1 agents, the most commonly used therapy in this cohort. Patients who developed ERAEs demonstrated improved overall survival during the follow-up period compared to those without endocrine toxicity. Conclusion In this cohort, systematic monitoring identified thyroid- and cortisol-related ERAEs in 9.6% of patients, consisting exclusively of post-thyroiditis hypothyroidism and ACTH deficiency. The occurrence of these endocrinopathies was associated with a favorable survival trend, underscoring the importance of early recognition and management of endocrine irAEs in patients receiving ICIs.


  • Open Access

    Late Diagnosis of Transaldolase Deficiency in an Adult Male with Hypergonadotropic Hypogonadism

    by Mohamed Tareq Al Abdul Razak, Raya Almazrouei

    Transaldolase deficiency is a rare autosomal recessive disorder of the pentose phosphate pathway, most often recognized in infancy or early childhood due to severe hepatic or hematologic manifestations. We describe the case of a 33-year-old man whose diagnosis emerged only in adulthood, following a prolonged and fragmented journey across multiple specialties. His presentation included hypergonadotrophic hypogonadism, persistent cytopenias, splenomegaly, and subtle but persistent cardiac anomalies. The eventual diagnosis was secured through genetic testing, which identified a homozygous pathogenic variant in the TALDO1 gene. This case highlights that transaldolase deficiency may manifest beyond childhood with insidious, multisystem involvement. It underscores the critical value of coupling meticulous clinical observation with targeted genetic testing in unveiling rare but clinically meaningful diagnoses.

  • Open Access

    Alpha-Lipoic Acid (ALA)-Related Insulin Autoimmune Syndrome

    by Hala Shahrour, Mohamed Alqedra, Raya Almazrouei

    Insulin autoimmune syndrome (IAS) is a rare cause of hypoglycemia characterized by autoantibodies against endogenous insulin, often triggered by sulfhydryl-containing compounds such as alpha-lipoic acid (ALA). We report the case of a 43-year-old previously healthy woman who presented with recurrent fasting and postprandial hypoglycemia. Biochemical evaluation revealed inappropriately elevated insulin and C-peptide levels with negative sulfonylurea screen and no pancreatic lesion on imaging. Further history uncovered recent use of ALA, and markedly elevated insulin autoantibodies confirmed the diagnosis of ALA-induced IAS. Discontinuation of the supplement and dietary modification led to complete resolution of symptoms. This case highlights the importance of considering IAS in the differential diagnosis of unexplained hypoglycemia and underscores the need for detailed medication and supplement history.

  • Open Access

    Diagnostic performance of morning basal serum cortisol for assessing adrenal reserve: a single-center experience from the United Arab Emirates

    by Raya Almazrouei, Jawaher Alshamsi, Mohamed Abdelsalhen, Fatima Alkaabi, Adnan Agha

    Introduction: Adrenal insufficiency can be life-threatening due to the lack of cortisol elevation in times of stress. The short Synacthen test (SST) is the most common diagnostic test for adrenal insufficiency. This study aimed to assess the diagnostic performance of morning basal serum cortisol during an SST to assess normal adrenal reserve in a local Emirati population. Methods: We retrospectively analyzed the electronic medical records of adult patients who underwent morning SST to assess adrenal reserve between August 2012 and August 2022. Results: This study included 344 patients (201 women) with a mean age of 49.1 ± 22.6 years. Based on the previously published cutoff data for SST peak values at 30 min (408 nmol/L for Beckman-Access used from 2012 to 2017 and 402 nmol/L for Roche-Cobas Generation-II used since 2018) as a gold standard to identify patients with adequate adrenal reserve, 106 patients (30.8%) were diagnosed with adrenal insufficiency and 238 (69.2%) with adequate adrenal reserve. Using the receiver–operator characteristics curve for morning cortisol, we identified a cutoff of 332 nmol/L, which corresponded to adequate Synacthen stimulation with 100% specificity and 73% sensitivity. Morning cortisol levels of 332 nmol/L can help identify patients with adequate adrenal reserve, thereby avoiding unnecessary SSTs.

  • Open Access

    Free Communications of the Gulf Association of Endocrinology and Diabetes Clinical Congress, October 18–20, 2024, Abu Dhabi, United Arab Emirates

    by Wiam I. Hussein, Thamer Alessa, Ali Alrisi, Bachar Afandi, Raya Almazrouei, Naji Aljohani

    These are the abstracts of the Clinical Congress of the Gulf Association of Endocrinology and Diabetes (GAED) held on October 18 to 20, 2024. The program included plenary lectures and clinical practice symposia delivered by international and regional key opinion leaders. In addition, free communications on current research and clinical practice within and beyond the Gulf region were presented as oral presentations and posters. We present here the abstracts of these free communications after minimal restyling and editing to suit the journal’s publication requirements. We hope that by publishing them in our open-access journal, we provide early recognition of the work and extend the benefit to those who could not make it to the live presentations, similar to our previous conferences. We also hope to stimulate networking between parties of mutual research interests.

  • Open Access

    Combined Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State as the First Presentation of Acromegaly: Case Report and Literature Review

    by Shamma Alshamsi, Hour AlSheleh, Raya Almazrouei

    Acromegaly is characterized by excessive growth hormone secretion and is usually associated with glucose intolerance or diabetes mellitus. It is rare to be associated with life-threatening diabetes emergencies. Here, we present a case of a 38-year-old woman who initially presented with a severe hyperglycemia crisis that meets the criteria for both diabetes ketoacidosis and hyperosmolar hyperglycemic state. Subsequently, she was found to exhibit signs of typical acromegaly, including enlargement of hands, thick skin, and interdental spacing. The diagnosis was established based on typical clinical manifestations, hormonal assays, and radiological findings confirming pituitary macroadenoma. Timely identification and diagnosis are crucial for mitigating the potential complications associated with this condition.


  • Open Access

    Awareness of Antithyroid Drug-Induced Agranulocytosis in Patients with Thyrotoxicosis

    by Nasser Abunamous, Akram Takaleh, Mohamed Abdelsalhen, Mohamed Alqedra, Amena Abbara, Raya Almazrouei, Adnan Agha

    Objective Anti-thyroid drugs (ATDS)-induced agranulocytosis is a serious side effect that can be treated by early management if the patient has been educated to promptly self-identify agranulocytosis based on its presenting features. We aimed to assess the knowledge of patients taking carbimazole for hyperthyroidism regarding suspected agranulocytosis. Methods This questionnaire-based cross-sectional study with prospective follow-up analyzed adult patients with hyperthyroidism who visited an endocrine clinic, in a tertiary hospital in the UAE, between January 2023 and March 2024. They were asked about their knowledge about the symptoms of agranulocytosis and the immediate steps required upon symptom observation. They were then given bilingual agranulocytosis information cards and educated either face-to-face or telephonically. Their knowledge and awareness were re-evaluated 3-6 months later. Chi-squared tests were used to assess the differences before and after patient education. Results The initial and follow-up surveys were answered by 68 patients (mean age: 43.7 ± 17.1 years). The cohort included 48 (70.6%) females and 58 (85.3%) Emiratis. Hypothyroidism was due to Graves' disease in 64 (94.1%) patients and toxic multinodular goiter in 4 (5.9%) patients. There were 41 (60.3%) participants who responded that they had received adequate information on ATD-related agranulocytosis upon treatment initiation, which improved to 67 (98.5%) following patient education. Similarly, their self-reported confidence in identifying ATD-related side effects significantly improved (50% [34/68] vs. 100% [68/68]; p < 0.00001) after receiving education. Conclusion Patient education and information cards on ATD-induced agranulocytosis improve patient awareness regarding symptom identification and the next steps required for suspected agranulocytosis.